Skip to main content

Advertisement

SpringerLink
Log in

Preoperative therapy: recent findings

  • Special Feature
  • New trends in primary systemic therapy for breast cancer
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Preoperative systemic therapy (PST) is the standard treatment for locally advanced breast cancer and a standard option for primary operable breast cancer. PST for breast cancer is as effective as postoperative adjuvant therapy, which permits more lumpectomies and can be used to study breast cancer biology. For locally advanced breast cancer patients, the primary aim of PST is to improve surgical option. For operable breast cancer patients, the primary aim of PST is to obtain freedom from disease. Because of recent advances in treatment and our understanding of the disease, we summarized the current consensus on the adoption and benefits of PST, especially for operable breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol. 1998;8:2672–85.

    Google Scholar 

  2. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: 9-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr. 2001;30:96–102.

    PubMed  Google Scholar 

  3. Van der Huge JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol. 2001;19:4224–37.

    Google Scholar 

  4. Kaufmann M, Hortobagi GN, Goldhirsch A, Scholl S, Makris A, Valagussa P, et al. Recommendation from an international expert panel on the use of neoadjuvant systemic treatment of operable breast cancer: an update. J Clin Oncol. 2006;24:1940–9.

    Article  PubMed  Google Scholar 

  5. Smith IC, Heys SD, Hutcheon AW, Miller ID, Payne S, Gilbert FJ, et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol. 2002;15:1456–66.

    Article  Google Scholar 

  6. Semiglazov, VF, Semiglazov, VV, Berstein LM (2003) In: Proceedings of SABC (abstract).

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgery, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

    Takayuki Kinoshita

Authors
  1. Takayuki Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takayuki Kinoshita.

About this article

Cite this article

Kinoshita, T. Preoperative therapy: recent findings. Breast Cancer 18, 80–84 (2011). https://doi.org/10.1007/s12282-010-0227-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12282-010-0227-4

Keywords

Search

Navigation